Stephen Frankel is a Respiratory physician affiliated with National Jewish Health. OpenAlex indexes 58 publications with 3,562 citations (h-index 25).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1400 Jackson St
Denver, CO 802062761
Telephone
303-398-1528Provider last certified this registry record 12 Nov 2020.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Siemens Medical Solutions USA, Inc.Program year20251 payment
- Siemens Medical Solutions USA, Inc.Program year20244 payments
- Celgene CorporationProgram year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
49.1%H2 blocker28.4%Famotidine100%Part D<11 patientsCorticosteroid20.7%Prednisone100%Part D<11 patientsAnti-infectives
18.1%Short-acting sulfonamides18.1%Sulfamethoxazole-Trimethoprim100%Part D<11 patientsRespiratory
17.2%Corticosteroid17.2%Trelegy Ellipta100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2002–2007 per NIH RePORTER. The latest:
- Death receptors, p53 and Akt in myofibroblast apoptosis.
National Jewish Health
FY2007$123,147K08HL067848 - Death receptors, p53 and Akt in myofibroblast apoptosis.
National Jewish Health
FY2006$123,147K08HL067848 - Death receptors, p53 and Akt in myofibroblast apoptosis.
National Jewish Health
FY2005$123,147K08HL067848
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- The Receptor Binding Domain of SARS-CoV-2 Lambda Variant Has a Better Chance Than the Delta Variant in Evading BNT162b2 COVID-19 mRNA Vaccine-Induced Humoral Immunity
International Journal of Molecular Sciences
2022 - The Lambda variant of SARS-CoV-2 has a better chance than the Delta variant to escape vaccines
bioRxiv (Cold Spring Harbor Laboratory)
2021
Similar KOLs
Other experts from the same institution or the same specialty.
James Crapo, MD
National Jewish Health
Barry Make, MD
National Jewish Health
Jeffrey Swigris, DO
National Jewish Health
Michael Wechsler, MD
National Jewish Health
Fernando Martinez, MD
University of Massachusetts Chan Medical School
David Gozal, MD
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”